Loss of cytomegalovirus-specific CD4+T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+T cell counts and recurrent retinitis

Krishna V. Komanduri, Judith Feinberg, Robert K. Hutchins, Ronald D. Frame, Diane K. Schmidt, Mohan N. Viswanathan, Jacob P. Lalezari, Joseph M. McCune

Research output: Contribution to journalArticlepeer-review

106 Scopus citations


Clinical histories are reported for 2 patients treated with highly active antiretroviral therapy (HAART) who experienced multiple relapses of cytomegalovirus (CMV) retinitis, despite suppression of human immunodeficiency virus type 1 (HIV-1) viremia and improvement in CD4+ T cell counts (to >400 cells/μL). CMV-specific CD4+ T cell immune reconstitution was measured directly, using cytokine flow cytometry, which revealed persistent deficits in CMV-specific CD4+ T cell responses in both patients. CMV-specific T cells constituted 0.14% and 0.05% of the total CD4+ T cell count in these patients, which is significantly lower than the percentages for 34 control subjects (0.6%-46%; CD4+ T cell count range, 7-1039 cells/μL; P = .019). Deficits in pathogen-specific immune responses may persist in some individuals, despite suppression of HIV-1 replication and substantial increases in circulating CD4+ T cells after HAART, and such deficits may be associated with significant morbidity from opportunistic infections.

Original languageEnglish (US)
Pages (from-to)1285-1289
Number of pages5
JournalJournal of Infectious Diseases
Issue number8
StatePublished - Apr 15 2001
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases


Dive into the research topics of 'Loss of cytomegalovirus-specific CD4<sup>+</sup>T cell responses in human immunodeficiency virus type 1-infected patients with high CD4<sup>+</sup>T cell counts and recurrent retinitis'. Together they form a unique fingerprint.

Cite this